Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.
Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.
Cas No. | 2023788-19-2 | SDF |
|
Formula | C225H348N48O68 | M.Wt | 4813.45 |
Solubility | Soluble in DMSO | Storage | Store at -20°C |
General tips | For obtaining a higher solubility, please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months. |
Shipping Condition | Secure |
Appearance: Powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
Weight Loss
Anti-diabetes
1.On the one hand, Tirzepatide activates GLP-1 receptors, which can regulate insulin secretion and glucagon release, strengthen blood glucose control, and also delay gastric emptying and suppress appetite.
2.On the other hand, activation of GIP receptors can reduce diet and increase calorie expenditure. At the same time, it can directly act on white adipose tissue, helping to improve the insulin sensitivity and fat buffering capacity of tissue cells, and improve blood flow and storage capacity.
3. Product Working Principle
4. Product Usage Precautions
Subcutaneous
The recommended starting dose is 2.5 mg subcutaneously once weekly, increasing to 5 mg after 4 weeks, and then in 2.5 mg increments based on treatment response and tolerance, up to a maximum dose of 15 mg subcutaneously once weekly.
Can be taken at any time of day, with or without food, into the abdomen, thigh, or upper arm, rotating the site with each.
Applicable P opulation : Improve blood sugar in adults with type 2 diabetes.
As a weight loss drug for adults who are obese (BMI 30 or above) or overweight (BMI 27 or above but with at least one weight-related comorbidity, such as hypertension, type 2 diabetes, or high cholesterol), with Manage your weight by reducing dietary calories and increasing exercise.
5. Product Long-term use Benefits
1. Helps slow food leaving your stomach
2. Helps prevent your liver from making too much sugar
3. Helps the pancreas produce more insul when your blood sugar levels are high
4. Can help control blood glucose
5. Can reduce hyperglycemia, especially after meals
6. Can reduce fasting insul and fasting glucose
7. Can reduce hemoglobin A1c
8. Can decrease appetite and caloric intake, while inhibiting weight gain
9. Has been shown to lower triglyceride levels and oxidative stress from high LDL
10. Has been shown to help induce weight loss in obese patients with higher dosing
11. Helps decrease leptin and increase leptin sensitivity
12. Can increase the conversion of white fat to brown fat
Notice of the storage
Should be stored in the refrigerator at 2°C to 8°C, away from light. If required, each single-dose pen can be stored unrefrigerated at a temperature not exceeding 30°C for up to 21 days, but once stored at room temperature it should not be returned to the refrigerator. If not used within 21 days after removal from the refrigerator, it should be discarded. Do not freeze tilpotide and if frozen, do not use.
8. Product Transportation
1.PayPal 2.Bank transfer 3.USDT 4.BTC etc.
About us
Xingtai Junyi Peptides Technology Co.,Ltd is a leading and dedicated pharmaceutical distributor committed to improving patient outcomes by facilitating access to innovative and life-changing medications. We specialize in the reliable, compliant, and efficient sourcing and distribution of high-demand therapeutics, with a core focus on Tirzepatide, a breakthrough treatment for Type 2 Diabetes Mellitus and chronic weight management.
Our Mission
Our mission is to bridge the gap between cutting-edge pharmaceutical innovation and the healthcare providers and patients who need it most. We achieve this by ensuring a seamless, secure, and transparent supply chain for critical medications like Tirzepatide, adhering to the highest standards of quality, regulatory compliance, and ethical business practices.
Core Focus: Tirzepatide Expertise
Tirzepatide represents a significant advancement in metabolic disease treatment. As specialists in this vital medication, we offer:
Reliable Supply:We maintain robust partnerships and supply chain networks to ensure consistent availability of genuine Tirzepatide.
Regulatory Compliance:We operate with strict adherence to all national and international regulations governing the pharmaceutical trade, including licensing, cold chain management (where applicable), and documentation.
Quality Assurance: We guarantee the authenticity and integrity of our products, sourcing only from authorized and vetted channels. Quality control is paramount at every stage.
Market Knowledge:Our team possesses deep expertise in the Tirzepatide market, its indications, and the evolving needs of healthcare providers and payers.
Efficient Distribution:We leverage optimized logistics to deliver Tirzepatide safely and promptly to pharmacies, hospitals, clinics, and authorized healthcare facilities.
Who We Serve: We partner with:
Pharmacies (Retail, Hospital, Specialty): Providing a dependable source for fulfilling patient prescriptions.
Hospitals and Healthcare Systems: Supporting formularies and patient care protocols requiring Tirzepatide.
Wholesalers & Distributors: Acting as a key supplier within the pharmaceutical supply chain.
Authorized Healthcare Providers:Facilitating access for clinics and practices treating eligible patients.
Our Commitment:
Patient-Centricity: Ultimately, our work enables better patient access to transformative therapies like Tirzepatide.
Integrity: We conduct business with transparency, honesty, and unwavering ethical standards.
Partnership: We strive to build long-term, collaborative relationships based on trust and mutual success with our clients.
Excellence: Continuous improvement in our processes and services is fundamental to our operations.
Why Partner With Us for Tirzepatide?
Choose Xingtai Junyi Peptides Technology Co.,Ltd for your Tirzepatide supply needs and benefit from our specialized focus, proven reliability, stringent compliance, and commitment to excellence. We are more than a distributor; we are a dedicated partner in advancing metabolic health.
Contact Us:
Learn how we can support your Tirzepatide requirements and become your trusted pharmaceutical partner.
Name:Domi
Email:domi@xtjytech.com
WhatsApp:+86 18331965818
United States
Kenya
